Purpose: This study assessed the effect of marital status on stage at diagnosis and survival in women with cervical cancer.
Background
Cervical cancer is the third most common gynecological cancer in women in the United States [1] . This disease is largely preventable with screening, early detection, and more recently, by vaccination. Yet, it is estimated that 12 900 new cases of invasive cervical cancer will be diagnosed and 4100 women would die of the disease in the United States in 2015. While the vast majority of cancers affect older people [1] , cervical cancer, lamentably, strikes relatively young women, with one of the youngest median age of diagnosis, 48 years old [2] . The most common histological type of cervical cancer is squamous cell carcinoma accounting for three-fourths of all cervical cancers [3] . Almost half of cervical cancers are detected at localized stage (46%), 36% are detected at a regional stage and 13% at a distant stage [4] . Survival is highest if the disease is found early; 91% of women diagnosed at a localized stage survive. Survival decreases significantly to 57% and 16% for those diagnosed at a regional and distant stage respectively [1] . Overall, survival from cancer of the cervix has been steady since the mid1900s at 70% [1] .
The cause of cervical cancer is the sexually transmitted infection with human papillomavirus (HPV), particularly, the high risk oncogenic types HPV 16 and HPV 18 [5] . Engaging in sexual activity at an early age or having multiple sexual partners increases risk for contracting the infectious agent and developing the disease [6] . Monogamy, therefore, may play an important role in the risk of the disease. While marriage is not the only, nor a guaranteed, form of monogamy, it is supposed that in general, those who are married are more likely to have exclusive sex partners than those who are not married. Previous studies have indeed shown that married women have a lower prevalence of HPV infection, particularly of the high-risk oncogenic HPV types, compared to other nonmarried women or women living with a partner [5] . In addition, studies show that being married often confers financial benefits and emotional support upon women, which can translate into higher socio-economic status, better health insurance, and a wider social network, all protective against many diseases [7] [8] [9] .
For other major cancer sites-lung, colorectal, breast, pancreatic, prostate, and liver-researchers have found unmarried cancer patients, whether single/never married, separated/divorced, and widowed, have later stages of detection and poorer survival compared to married patients [10] [11] [12] [13] [14] [15] . However, for cervical cancer, the research shows mixed results. Some studies found a survival advantage among married women in relation to unmarried women, while other studies failed to confirm such results [11, 13, 16] . Moreover, to date, few studies have specifically examined the association between marital status and stage at diagnosis of cervical cancer.
To bridge these gaps in the literature, we used the most recent data from the population-based databases of the Surveillance, Epidemiology and End Results (SEER) Program to examine the association between marital status and stage at diagnosis of cervical cancer as well as marital status and survival from cervical cancer. A better understanding of the extent to which marital status is a risk factor for differences in cervical cancer outcomes will assist in identifying those women at increased risk who would likely benefit from targeted cancer prevention and control interventions.
Methods
We identified cervical cancer cases from the SEER program of the National Cancer Institute. SEER registries maintain high quality standards and report timely, accurate, and continuous data. They monitor cancer trends and provide information on patient demographics, primary tumor site, specific cancer markers, cancer stage at diagnosis, and patient survival. The SEER coverage areas represent approximately 28% of the U.S. population. Participating registries include nine states (New Mexico, Hawaii, Utah, Iowa, Connecticut, Greater California, Kentucky, Louisiana, New Jersey), five metropolitan areas (Metro Atlanta plus a sample of rural Georgia, the Greater Bay Area [San Francisco-Oakland and San-Jose Monterey], Los Angeles, Seattle, Detroit), and the Alaska Native Tumor Registry [17] .
Cases diagnosed with primary invasive cervical cancer between 2000 and 2010 were identified using the International Classification of Diseases for Oncology, Third Edition, (ICD-O-3) codes: C53.0, C53.1, C53.8, and C53.9. We excluded the following five groups of patients from our study: diagnosed younger than 15 years old, in-situ stage, reported through a death certificate only, diagnosed with two or more malignancies of any kind, and diagnosed with sarcoma cell type. A final number of 31 425 cases of invasive cervical cancer were included in the analysis.
Covariates and outcome variables
We used SEER historic stage, a simpler staging classification system normally used in population-based studies, rather than the American Joint Commission on Cancer (AJCC) staging [17] . Stage variables included localized, regional, distant, and unknown stage. For the purpose of assessing risk of advanced stage at diagnosis, we combined regional and distant stages into a single category, which we called advanced stage. Survival is recorded in the database as the number of months from the date of diagnosis to the date of death, or to the date of last alive contact, or to the date of the last follow-up cutoff date of December 31, 2010, whichever occurred first.
Marital status was gathered in four categories: married, single (never married), separated/divorced, and widowed. We then combined all three non-married groups (single, separated/divorced, or widowed) to get a dichotomized variable of married vs. unmarried. We used age groups (15- 
Statistical analyses
Patient characteristics were analyzed by marital status. Frequencies were compared using the likelihood Chisquare test. Diagnosis at advanced vs. localized stage by marital status was compared while controlling for age, race/ethnicity, period of diagnosis, SEER area, histology, and insurance for select cases. We obtained odds ratios and their 95% confidence intervals (CI) from the multivariate logistic regression models. To compare differences in survival between marital status categories, hazard ratios were calculated using the Cox proportional hazards regression models. These models were adjusted for age, race/ethnicity, period of diagnosis, stage at diagnosis, SEER area, and histology. Interactions between marital status and stage were tested, and where interaction terms were found significant at p < 0.05, the model was stratified by the covariate. Survival differences between the unmarried categories (singles vs. separated or divorced, singles vs. widowed, and separated or divorced vs. widowed) were also compared.
In April 2013, the SEER program released data about insurance status at diagnosis for cancer cases diagnosed from 2007 through 2010. The insurance variable includes the following broad categories: insured, uninsured, insured under Medicaid, and unknown insurance status. Using these data we carried out a sub-analysis including cases from 2007 to 2010 only, to examine how adjusting for insurance status might affect the odds for stage at diagnosis and the hazard ratios for survival. All p values are two-sided and significant at p < 0.05. All analyses were conducted using version 9.2 of the SAS statistical software (SAS Institute, Cary, NC). This study was deemed exempt by the Biomedical Institutional Review Board of the University of Nevada, Las Vegas under Protocol # 1308-4542M.
Results
Our cohort included 31 425 women diagnosed between 2000 and 2010 with a first and unique primary cervical cancer. Patient demographic and clinical characteristics differed significantly between all marital groups (Table 1) . Overall, almost half, 46.3%, of all cases were married at the time of diagnosis: 14 543 cases. Married and single patients were younger (less than 44 years old) at the time of diagnosis compared to separated and widowed patients (48% and 57% vs. 35% and 4% respectively, p < 0.001). Significant clinical differences were found between marital status groups. More married patients were diagnosed at a localized stage (7984, 55%) than patients in other marital groups (47% of singles, 42% of separated/divorced, and 28% of widowers, p < 0.001). Advanced stage was highest among widowed women (2201, 65%) and lowest among married women at 48%. Histological types also differed between married and unmarried patients (p < 0.001). For diagnosis periods, there was a downward trend in the absolute number of cases diagnosed from the earliest to the most recent years included in our study. This trend was somewhat similar across marital status groups with married women experiencing a considerable drop in number of cases of 12% points from the first period (2000) (2001) (2002) (2003) to the third period (2008) (2009) (2010) (Table 3) .
Other predictors independently associated with excess risk of death from cervical cancer were increased age, Black race, advanced stage, and histology. In the models that controlled for insurance status, unmarried women were still at higher risk of advanced diagnosis and poorer survival compared to married women, although the magnitude of the effect was somewhat smaller ( Table 2 ). The effect of marital status on survival was modified by stage. After stratification by stage, the impact of marital status was not significantly different between unmarried women diagnosed at a distant stage and their married counterparts. Stratifying by stage showed the greatest death risk disparity in women diagnosed at the localized stage: single women were 66% more likely to die than their married counterparts (Table 3) .
We also compared survival between the unmarried categories in separate models. Single women, with the most unfavorable prognosis, were 11% more likely to die than separated/divorced women (HR 1.11; 95% CI 1.04-1.18) ( Table 4 ).
Discussion
Marital status is an independent predictor of stage at diagnosis and survival in women with cervical cancer. Unmarried women, including single, separated or divorced, and widowed, are being diagnosed more often at an advanced stage and have poorer survival compared to married women. The survival advantage of married women was further confirmed after accounting for demographic and clinical factors. Moreover, insurance status is not the source of this disparity. When stratified by stage, separated or divorced and widowed women diagnosed at a distant stage had comparable survival as their married counterparts, likely because of the poor prognosis of distant stage regardless of other determinants. Among the unmarried categories, single women were at higher death risk in relation to separated or divorced women. Overall, single women have the poorest outcomes compared to all other marital groups. To our knowledge, this is the first study to compare cervical cancer outcomes among the unmarried. This study is important because it reaffirms that marital status is significantly associated with cancer outcomes, particularly for cervical cancer. Moreover, this study showed that disparities in cervical cancer outcomes by marital status are more pronounced than racial disparities, which have long been the focus of health disparities research.
Presentation with advanced cervical cancer can be prevented by regular screening with the Papanicolaou test and HPV DNA test [18, 19] . In our study, we observed that married women are more likely to be diagnosed at the early stages of the disease where treatment is more effective. Previous research found that unmarried women have lower cervical cancer screening rates than married women [20] . These lower rates likely account for the outcomes observed in our study, yet reasons for lower screening rates among unmarried women are unclear. Other factors, such as financial and social support and health insurance access, could contribute to this disparity. On a population basis, marriage is characterized with improved socioeconomic status, especially for women. Recently divorced women are more likely to be living in poverty and be receiving public assistance compared to men as well as married women [21] . In addition, married women benefit from social support which is positively associated with cancer screening, including the Pap smear [22, 23] . Moreover, married women are more likely to have private health insurance coverage compared to the unmarried [24, 25] . Nevertheless, controlling for insurance status in our study did not change the fact that married women had favorable outcomes. Likewise, Osborne and colleagues observed that unmarried breast cancer patients have higher mortality compared to married patients, despite the fact that all participants in their study were Medicare beneficiaries [26] . Furthermore, women with melanoma who were widowed were also found to have poorer survival in relation to married women, even when all were insured under Medicare [27] . All these findings raise concerns about whether unmarried women receive adequate preventive care irrespective of insurance status and provide evidence-based arguments to increase attention to this vulnerable group.
We observed a sustained advantage of married women in terms of survival even after controlling for stage at diagnosis and insurance. This finding is consistent with other studies [28] [29] [30] . A clear definitive explanation of such advantage has yet to be determined. In our study we were not able to control for individual level socioeconomic status (SES) as this information does not exist in the SEER data. Other studies have used ecological measures as proxies for SES [10, 31, 32] . In all these studies, married cancer patients had a survival advantage over the unmarried. Moreover, researchers have described a potential influence of psychosocial support on cancer survival [33, 34] . When present in the form of social support [35, 36] or supportive group therapies [37] , psychosocial support proves to be crucial to help deal with potential emotional distress and anxiety when coping with cancer.
Whether spousal social support is equivalent to social support in a supportive group therapy setting is unclear. Although supportive group therapy may be more structured and scientifically based, it may be insufficient compared to the continued daily support a spouse may confer to his/her partner when dealing with a cancer diagnosis. A spouse, likely more familiar with the needs and wants of his/her partner, may be better prepared and more willing to respond to those needs. Studies are needed to assess the potential differences in these types of social support in order to discern the unique manner in which marriage contributes to better cancer outcomes.
The survival difference within the unmarried categoriessingle, separated/divorced, and widowed-although minimal, is an intriguing finding. Single women had the worst outcomes compared to the other groups. While divorced and widowed women may still have close family support, possibly remnant from past relationships, single women may suffer from social isolation because of a continuum of an autonomous life style with less engagement in social networks in general. While Kroenke et al. found no significant mortality differentials by marital status in a study of breast cancer patients; they did find that those who were socially isolated had increased mortality risk. In their study, women who were not married, had few friends or relatives, and were not associated with any church or community groups before diagnosis had a twofold increased risk of breast cancer mortality compared to those who were more socially integrated [8] . Recent marriage trends add to the relevance of this study. Marriage rates in the United States are steadily falling. In 2011, less than half of American households were composed of married couples compared with over three quarter of households in the 1950s [38] . In addition, fewer women marry at an early age [39] possibly resulting in multiple sexual partners which can increase the risk of HPV transmission.
Results of this study should be considered in light of some limitations. First, data are not available on some other important factors such as individual level socialeconomic status, individual Pap test history, smoking status, and co-morbidities. Cancer registries do not collect these variables as part of the surveillance system. Second, marital status is recorded at the time of diagnosis; any later changes in marital status are not reported. In addition, the married category is not further defined by whether the spouses are opposite or same sex. With the recent legalization of same sex marriage, registries will need to capture this aspect to help clarify the effect of marriage on cancer outcomes. Third, we found that Hispanics and Asians/Pacific Islanders had a lower risk of death than Whites, but this finding should be interpreted with caution given the different completeness of follow-up of cancer cases for these two minority populations [40] . Last, we cede that using marital status alone may not give perfectly accurate information about the relationship status of women with cervical cancer. Naturally, many women are living in de facto partnerships, whether same or opposite sex, while not legally married. This may contribute to some degree of misclassification of the positive attributes, e.g. social support that marriage encompasses. As such, our estimates of the effect of marriage in this study are an underestimate of the true impact of a committed relationship on cancer outcomes.
Conclusion
In summary, we observed poorer prognosis for unmarried women with cervical cancer compared to married women, especially among single women. Given that the number of unmarried women is on the rise, the emphasis on early detection of cervical cancer is crucial in this at risk population. Several aspects need to converge in a synchronized approach in order for unmarried women to achieve gains in terms of earlier stage at diagnosis and improved survival outcomes. These factors should include increased provider and patient engagement, expanded health insurance coverage, improved quality of care, public health interventions, and implementation and monitoring of evidence-based recommendations including the use of HPV tests alongside Pap tests and uptake of HPV vaccination. Interventions to mitigate these issues are strongly needed.
